Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 TherapyJie Mei, Rong Guo, Wei Wei et al.|Journal of Inflammation Research|2021Cited by 49
Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathwayJie Mei, Rong Guo, Yuhao Tang et al.|Journal of Experimental & Clinical Cancer Research|2022Cited by 30
The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early‐stage hepatocellular carcinomaZhi-yuan Chen, Rong Guo, Jie Mei et al.|Cancer Medicine|2021Cited by 23
Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapyMin Deng, Rong Guo, Shaohua Li et al.|Annals of Medicine|2022Cited by 22
Resection vs. Sorafenib for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Real World, Propensity Score Matched Analytic StudyJie Mei, Rong Guo, Shaohua Li et al.|Frontiers in Oncology|2020Cited by 17